Glucose + Nacl B. Braun

Glucose + NaCl B. Braun is an injectable solution that combines sodium chloride and glucose monohydrate. It is supplied as a sterile intravenous fluid without a specified concentration, intended for fluid, electrolyte, and energy replacement in clinical settings. The product is marketed in the European Union and requires a prescription.

Glucose + NaCl B. Braun is used when patients need rapid restoration of fluid volume, electrolytes, and an energy source. It is commonly administered in hospitals and other healthcare facilities.

- Fluid replacement in dehydration or blood loss - Electrolyte replenishment, especially sodium deficits - Provision of an immediate carbohydrate source for metabolic support - Adjunct to parenteral nutrition regimens - Support during surgical procedures or anesthesia - Management of hypoglycemia when combined with glucose delivery

Side effects may occur with any intravenous solution, though many patients tolerate the product without issues.

Common: - Mild infusion site irritation or erythema - Transient hyperglycemia - Slight increase in serum sodium levels - Nausea or mild gastrointestinal discomfort - Headache or dizziness - Low-grade fever

Serious: - Severe hypernatremia leading to neurologic symptoms - Significant hyperglycemia requiring medical intervention - Allergic reaction such as urticaria or anaphylaxis - Fluid overload causing pulmonary edema - Electrolyte imbalance with severe hyponatremia or hyperkalemia - Hemolysis in patients with incompatible solutions

Healthcare professionals should assess patient-specific factors before administering Glucose + NaCl B. Braun.

- Verify serum electrolyte and glucose levels prior to infusion - Adjust infusion rate in patients with cardiac or renal insufficiency - Use caution in neonates, infants, and the elderly due to altered fluid balance - Monitor for signs of fluid overload, especially in postoperative patients - Avoid rapid administration in patients at risk for cerebral edema - Ensure compatibility with other intravenous medications before mixing - Document any adverse reactions and report to pharmacovigilance systems

Glucose + NaCl B. Braun may interact with other intravenous therapies or systemic medications.

Avoid: - Co-administration with hypertonic saline solutions that could exacerbate hypernatremia - Simultaneous infusion of potassium chloride without proper monitoring, risking hyperkalemia - Use with drugs that cause fluid retention, such as corticosteroids, without dose adjustment

Use with caution: - Concurrent insulin therapy, as glucose infusion may affect glycemic control - Diuretics, which can alter electrolyte balance during fluid replacement - Antihypertensive agents, especially ACE inhibitors, due to potential changes in volume status - Medications affecting renal function, such as NSAIDs, requiring close monitoring of electrolytes